From Name:
From Email:
To Name:
To Email:

Optional Message:


FDA outlines path for lower-priced biotech drugs

from The Associated Press via USA Today

The Food and Drug Administration is preparing to review the first lower-cost versions of biotech drugs, expensive medications which have never before faced generic competition. The guidelines issued by the FDA are the final step in a decades-long effort to lower the price of biotech drugs, high-tech injectable medications that cost the nation billions of dollars each year. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063